Article · Revue · 2021

A SARS-CoV-2 nucleocapsid ELISA represents a low-cost alternative to lateral flow testing for community screening in LMI countries

Maria V. Humbert, Precious Opurum, Nathan J. Brendish, Stephen Poole, Peijun He, Ioannis Katis et 11 autres

Journal of Infection

• Accès ouvert · Bronze
• International · 2 pays

Le lire10.1016/j.jinf.2021.08.049